pyrazolanthrone has been researched along with Diabetic Cardiomyopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Liang, G; Liu, Q; Liu, Y; Miao, X; Sun, J; Tan, Y; Wang, Y; Zheng, Y; Zhou, S | 1 |
1 other study(ies) available for pyrazolanthrone and Diabetic Cardiomyopathies
Article | Year |
---|---|
Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes.
Topics: Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Curcumin; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; JNK Mitogen-Activated Protein Kinases; Male; Mast Cells; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |